PAUL WILLIAM HUMPHREY, M.D.

Plain English
This study looked at how well transperineal ultrasound (TPUS) can track prostate movement during radiation therapy compared to the standard imaging method, cone-beam computed tomography (CBCT). The results showed that TPUS was accurate in aligning with CBCT 88.3% of the time laterally, 79.4% longitudinally, and 86.7% vertically. Importantly, prostate movement that exceeded 3 mm during treatment happened in 40% of the sessions, and using TPUS helps ensure that radiation stays where it’s needed while protecting nearby organs. Who this helps: This benefits patients undergoing prostate radiation therapy by improving treatment accuracy and safety.

Plain English
This study focuses on a new tool called spEMO that combines different types of biological data, specifically gene and protein expression with tissue images, to improve our understanding of diseases. The researchers found that spEMO outperformed older models in various tasks, helping identify disease types and interactions within cells more accurately. This development is important because it enhances both scientific research and medical diagnoses, making it easier to understand complex diseases. Who this helps: This helps researchers and doctors by providing better tools for analyzing and interpreting medical data.

Plain English
This study looked at how patients with lower limb soft tissue sarcoma experience rehabilitation after surgery in the UK. It found that while patients received good care in the hospital after surgery, they faced delays in accessing support and services afterward, creating gaps in their recovery. Communication was crucial; when patients understood their recovery process better, they felt more supported and engaged in their rehabilitation. Improving access and communication across all stages of treatment can help patients recover more effectively. Who this helps: This research benefits patients undergoing surgery for lower limb soft tissue sarcoma.

Plain English
This study looks at the management of non-muscle invasive bladder cancer (NMIBC), which is a type of bladder cancer that hasn't spread deeply. It found that new genetic markers could help personalize diagnosis and treatment for patients, while new immunotherapy treatments are available for those whose cancer doesn’t respond to conventional therapy, even though some challenges exist like high costs and side effects. The research is important because it aims to provide more effective and tailored treatment options, reducing unnecessary procedures and improving patient outcomes. Who this helps: This helps bladder cancer patients and their doctors.

Plain English
This paper looks at current treatment recommendations for testicular cancer, focusing on two types: seminomas and nonseminomas. It highlights the guidelines established by the National Comprehensive Cancer Network (NCCN), which detail how doctors should diagnose and treat this type of cancer. This is important because following these guidelines can lead to better outcomes for patients, ensuring they receive the right care based on the latest research. Who this helps: This helps patients with testicular cancer and their doctors.

Plain English
This study looked at how the removal of lymph nodes during surgery for a specific type of bladder cancer called variant subtype bladder cancer (VBC) affected patient survival. Researchers analyzed data from over 30,000 patients and found that while lymph node dissection (LND) generally improved survival, it significantly helped those with squamous and adenocarcinoma subtypes, increasing their average survival times from 37.2 to 71.0 months and 37.9 to 45.9 months, respectively. Understanding these relationships is crucial because it can guide doctors in making treatment decisions tailored to different cancer subtypes. Who this helps: Patients with variant subtype bladder cancer and their doctors.

Plain English
This research paper discusses the advancements in a method called 3D pathology, which allows doctors to study thick tissue samples in a detailed way without cutting them into thin slices. The authors highlight that while this method produces large amounts of valuable data, it can be challenging for doctors, as they aren't traditionally trained to read this type of complex information. The study emphasizes the importance of using artificial intelligence to help doctors make sense of these large datasets, which can lead to better diagnoses. Who this helps: This helps doctors and pathologists who analyze tissue samples for disease.

Plain English
This study looked at the experiences of women who received brachytherapy for locally advanced cervical cancer, focusing on what they went through and how their care could be improved. Researchers interviewed 35 patients, ranging in age from 28 to 87, and found that many experienced severe pain and felt their care was lacking. However, some also shared positive aspects of their treatment. Overall, the findings highlighted the need for better support and care practices in brachytherapy to reduce distress for patients. Who this helps: This helps patients undergoing brachytherapy and healthcare providers looking to improve patient care.

Plain English
This study looked at the occurrence, treatment, and survival rates of adult patients with primary renal sarcomas, a rare type of kidney cancer, from data between 2004 and 2016. Researchers found that there were about 0.53 new cases per million people each year, with the most common types being leiomyosarcoma and malignant rhabdoid tumors. Many patients had advanced disease at diagnosis, yet those who were younger, female, and had better overall health and specific tumor characteristics tended to live longer after treatment. Who this helps: Patients with renal sarcomas and their doctors can use this information to better understand the disease and treatment options.

Plain English
This study focused on improving the way we analyze human tissue samples, specifically for prostate cancer, by using a new AI system called TriPath that processes 3D images of tissues instead of traditional 2D slices. The researchers found that this 3D approach provides better predictions for patient outcomes, performing significantly better than standard methods and even better than evaluations from six certified pathologists. By looking at more comprehensive tissue structures, the new method reduces errors stemming from sampling bias and gives doctors more accurate insights into cancer recurrence risk. Who this helps: This benefits patients with prostate cancer and their doctors by providing more accurate risk assessments.

Plain English
This study looked at how well three different treatments—sunitinib, cabozantinib, and others—worked for patients with advanced papillary renal cell carcinoma (PRCC), a type of kidney cancer. The researchers found that cabozantinib led to a median overall survival of 21.5 months, while sunitinib resulted in 17.3 months, but there was no significant difference in survival between the two treatments. This is important because while cabozantinib is still a viable option, it highlights the need for new and improved treatments for patients with advanced PRCC. Who this helps: This helps patients with advanced PRCC and their doctors seeking effective treatment options.

Plain English
This study looked at treatment patterns and survival rates for patients with a rare bladder cancer called plasmacytoid urothelial carcinoma (PUC) by analyzing data from the National Cancer Database and Yale School of Medicine. Researchers found that the average survival time for patients was about 28 months, with those receiving chemotherapy before surgery (neoadjuvant chemotherapy) living longer—around 60 months—compared to just 15 months for those who did not get this treatment. However, the overall benefit of this chemotherapy on survival wasn't clear when considering other factors like the stage of the cancer. Who this helps: This information is valuable for doctors treating patients with this specific type of cancer.

Plain English
This study looked at the levels of antibodies in people from four counties in Liberia to see if they had been exposed to SARS-CoV-2, the virus that causes COVID-19, as well as other viruses like Dengue and Chikungunya. Researchers tested 189 blood samples and found that many people showed signs of having been exposed to SARS-CoV-2 and other viruses. This is important because it helps health officials understand the spread of these viruses in Liberia, enabling better public health responses. Who this helps: This helps patients and health officials in Liberia and other low- to middle-income countries.

Plain English
This study focused on improving the care given to patients undergoing brachytherapy for locally advanced cervical cancer by developing better recommendations. Researchers created 51 initial recommendations based on patient feedback and then held workshops with doctors and patients to refine and prioritize these suggestions. Ultimately, 25 recommendations received top scores, with 46 others rated highly, helping to create a solid foundation for future guidelines that aim to enhance patient experiences and standardize treatment. Who this helps: This benefits patients receiving brachytherapy and healthcare providers involved in their care.

Plain English
Researchers reviewed recent advancements in machine learning tools used for analyzing images in the field of genitourinary pathology, which focuses on diseases of the urinary and reproductive systems. They found that these tools can improve the evaluation of tumors by providing better information on their grade, stage, and type but noted that challenges such as insufficient data, regulatory hurdles, and a lack of standardization are slowing down their use in practice. This is important because effective tumor assessment can lead to better treatment outcomes for patients. Who this helps: Patients with genitourinary cancers.

Plain English
This study focused on creating a list of quality indicators for radiation therapy in cervical cancer treatment to ensure high standards of care. Researchers identified 19 indicators, which include guidelines about pre-treatment procedures, the timing of treatment, actual radiation therapy delivery, and patient outcomes. This helps standardize radiation therapy and improve care for cervical cancer patients across different medical centers. Who this helps: This benefits patients undergoing treatment for cervical cancer.

Plain English
Researchers developed a set of quality indicators to improve radiation therapy for cervical cancer. They identified 19 key indicators related to treatment processes and patient outcomes, drawing on expert consensus and scientific evidence. These indicators aim to standardize care and enhance the effectiveness of radiation treatments, ultimately leading to better patient outcomes. Who this helps: This benefits doctors and healthcare providers working with cervical cancer patients.

Plain English
This study looked at the effectiveness of four drugs—sunitinib, cabozantinib, crizotinib, and savolitinib—in treating advanced papillary renal cell carcinoma, a type of kidney cancer. Researchers found that patients taking cabozantinib had a longer time without disease progression (9 months) compared to those taking sunitinib (5.6 months), and cabozantinib also had a higher response rate (23% vs. 4%). These findings are important because they offer a more effective treatment option for patients with this aggressive cancer, potentially improving their quality of life and survival. Who this helps: This benefits patients with advanced papillary renal cell carcinoma.

Plain English
This study looked at how brachytherapy, a treatment for locally advanced cervical cancer, is provided across different centers in the UK. The survey found that 65% of centers offered this treatment to patients as inpatients, while 35% allowed for day cases; treatment durations varied greatly, ranging from 3 to 52 hours. The findings highlight significant differences in the quality of care and support, indicating a need for better training and post-treatment follow-up to improve women's experiences. Who this helps: This helps patients receiving brachytherapy for cervical cancer.

Plain English
The Men's Eating and Living (MEAL) study looked at how practical it is to conduct national trials that test the impact of a high-vegetable diet on men with localized prostate cancer who are on active surveillance. From 2011 to 2015, 478 men were enrolled across 91 sites, achieving successful recruitment beyond their goal of 464. The study found that the participants had a mean age of 64 and an average PSA level of 4.9 ng/mL, proving it is feasible to run large dietary intervention trials in this patient group. Who this helps: This research benefits men with prostate cancer on active surveillance, offering potential dietary strategies to help manage their condition.

Plain English
This study looked at the genetic differences within small and large kidney tumors, specifically a type called clear cell renal cell carcinoma. Researchers analyzed 47 tumors and found that small tumors (less than 4 cm) had significantly fewer genetic variations and complexities compared to large tumors (more than 7 cm), with less than 0.001 frequency of certain genetic changes. This matters because it suggests that testing small tumors with a biopsy may be effective for understanding their behavior and guiding treatment options. Who this helps: This helps patients with small renal tumors and their doctors by providing clearer insights for treatment decisions.

Plain English
This study looked at how women feel about receiving brachytherapy, a treatment for cervical cancer. The review found that 90% of the women reported feeling anxious and distressed during the procedure, highlighting the need for better pain management and support. Improving how patients are informed and including non-drug interventions can help make the experience less stressful. Who this helps: This research benefits women undergoing treatment for cervical cancer, as well as healthcare providers looking to improve patient care.

Plain English
This study looked at small kidney tumors, specifically how their size relates to serious characteristics that can worsen patient outcomes. Researchers analyzed 380 tumors and found that larger tumors were more likely to show harmful features; for instance, 49% of tumors between 3 to 4 cm had at least one bad characteristic, compared to only 22% of those 1 cm or smaller. Understanding these patterns helps doctors make better decisions about monitoring and treating kidney tumors. Who this helps: This information benefits doctors and patients with small kidney tumors.

Plain English
This study looked at how well a specific imaging score (PI-RADS v2) predicts prostate cancer when a patient has one suspicious spot on an MRI. Out of 176 men, cancer was found in 60.2%, and 69.8% of those had a more serious type of cancer (Gleason score 7 or higher). The strongest prediction for detecting this serious cancer came from categories in the imaging assessment, especially in certain areas of the prostate. Who this helps: This helps doctors better identify and treat patients at risk for serious prostate cancer.

Plain English
This study focused on how testicular cancer specimens are handled and reported by pathologists in Europe. Among 250 professionals surveyed, there was a notable disagreement on certain aspects: for example, 68% of pathologists identified teratoma immaturity as a concern while only 32% of experts did. These disagreements, especially in cancer staging, can lead to different treatment choices for patients, which is critical for effective care. Who this helps: This helps patients with testicular cancer by ensuring more consistent and accurate diagnoses.

Plain English
The Men's Eating and Living (MEAL) Study is examining whether eating more vegetables can slow the growth of early-stage prostate cancer in men who are closely monitoring their condition instead of starting immediate treatment. The study involves 464 men, with half receiving phone-based diet counseling to increase their vegetable intake, while the other half gets general dietary guidelines. This research matters because it aims to determine if dietary changes can reduce the risk of cancer worsening, which could lead to fewer treatments and better quality of life for patients. Who this helps: This helps men with early-stage prostate cancer and their healthcare providers.

Plain English
Researchers studied the changes in classifications and understanding of kidney tumors over the past several decades. They found that the number of recognized types of kidney tumors has grown from 9 in 1981 to 50 by 2004, with ongoing updates to classification based on their features. This matters because better classification helps doctors provide more accurate diagnoses and treatments for patients with kidney tumors. Who this helps: This benefits patients with kidney tumors and the doctors treating them.

Plain English
This study looked at how well a specific cancer treatment, called vaginal vault brachytherapy, worked for 105 women with endometrial cancer. Researchers found that using CT imaging improved the positioning of the treatment device, resulting in more than 93% of the patients (96 out of 103) having good contact during their treatment. This improvement is important because it can lead to more effective and comfortable treatments for patients. Who this helps: Patients with endometrial cancer receiving brachytherapy.

Plain English
This study looked at why bladder cancer occurs more often in men than in women. Researchers found that in a mouse model, 40% of male mice developed bladder tumors in 12 weeks, while only 3% of female mice did. The study reveals that interactions between certain cellular signals (β-catenin and the androgen receptor) contribute to this difference, which helps us understand the biological reasons behind the higher cancer rates in men. Who this helps: This helps doctors and researchers working on bladder cancer treatment and prevention.

Plain English
This study looked at the role of a protein called Trop2 in the development of squamous cell carcinoma, a type of skin cancer. Researchers found that when Trop2 was absent in mouse models, it did not prevent cancer formation but instead led to more aggressive tumor behavior, including a change in cell type that promotes cancer spread. Overall, they discovered that tumors with lower levels of Trop2 are more likely to show aggressive features, indicating that loss of Trop2 may contribute to harsher forms of cancer. Who this helps: This benefits researchers and doctors focusing on skin cancer treatments and understanding tumor behavior.

Plain English
The British Association of Stroke Physicians (BASP) has been working for nearly 10 years to improve stroke care in the UK. It includes over 340 specialists and 240 trainees, and has significantly enhanced training, research, and support for stroke services. This matters because better-trained professionals and improved services lead to better outcomes for stroke patients, despite ongoing challenges in the field. Who this helps: This helps patients who have had or are at risk of strokes, as well as the doctors treating them.

Plain English
This study explored a new agent to help make it easier to slice tough tissue samples, which are often used in medical diagnostics. The researchers tested four new, safer formulations against a standard phenol-based product and found that the new agents worked faster and produced better-quality slices without harmful effects. This is important because it means less risk for lab workers and better results for tissue analysis. Who this helps: This benefits pathologists and laboratory technicians who handle tissue samples.

Plain English
This paper discusses the push for standardized reporting in pathology reports for prostate cancer to improve consistency and quality of information useful for patient care. The American College of Surgery's Commission on Cancer now requires specific essential details to be included in pathology reports at accredited cancer centers, which means these centers must use updated checklists developed by pathology experts. These checklists will help pathologists report necessary information clearly and are adaptable for different cases, improving overall patient management and outcomes. Who this helps: This helps patients and doctors by ensuring better quality and consistency in cancer diagnosis and treatment planning.

Plain English
This study looked at the effectiveness of five different tools, called nomograms, that predict outcomes for patients with localized prostate cancer after surgery. Researchers analyzed 327 cases and found that one of the tools, the Kattan nomogram, performed the best with an average information content of 0.44, meaning it accurately predicted outcomes for half the patients. However, since it still provided useful information for less than half of the cases, there’s a need for improvements, potentially by including more details from biopsy samples. Who this helps: This research benefits prostate cancer patients and doctors by identifying better ways to predict treatment outcomes.

Plain English
This study compared two surgical techniques for connecting the bladder to the urethra in pigs: running sutures and interrupted sutures. Researchers found that running sutures took about 27.5 minutes to complete, while interrupted sutures took 36.8 minutes, but both methods showed the same rate of leakage. However, there was more muscle scarring in the interrupted suture group, which could affect healing. Who this helps: This research benefits surgeons by providing insights into suturing techniques for bladder surgery.

Plain English
This study looked at how controlling blood flow to the kidneys and cooling the kidney tissue during a cryoablation procedure affects the size of kidney damage in pigs. The researchers found that when both blood flow was stopped and the kidney tissue was cooled, the area of complete tissue damage was larger (34.3 mm) compared to just stopping blood flow (27.8 mm) or using traditional methods alone (23.9 mm). This matters because it suggests that using cooling during cryoablation could make the procedure more effective for treating kidney conditions. Who this helps: Patients needing kidney treatments.

Plain English
This study looked at the drug dutasteride, which blocks two enzymes involved in producing a hormone related to prostate cancer. It found that men who took dutasteride for 45 days or longer experienced a 97% drop in a hormone linked to cancer growth and showed signs of tumor cell death, which is a positive sign for cancer regression. These results suggest that dutasteride could be effective in shrinking prostate tumors, making it an important option for early cancer treatment. Who this helps: This helps patients with early-stage prostate cancer.

Plain English
Researchers studied how adults with sudden neurological issues are cared for in UK hospitals and found that most don’t actually see a specialist called a consultant neurologist. There’s a clear need for more neurologists; the number should rise from around 400 to about 1,400 to improve patient care over the next 10-15 years, matching the standard seen in other European countries. This matters because better access to specialists can lead to improved treatment outcomes for patients with serious neurological conditions. Who this helps: This helps patients with acute neurological problems.

Plain English
This study looked at a serious brain disease called subacute sclerosing panencephalitis, which usually occurs after measles and is almost always fatal. The patient involved in the study received a combination of interferon-alpha, ribavirin, and inosiplex and showed significant improvements; his condition got better over the 10 weeks he was treated, allowing him to leave the hospital. However, after 10 months, his health declined rapidly, and he passed away before more treatment could be given. Who this helps: This research benefits patients with subacute sclerosing panencephalitis and their families.

Plain English
This study looked at how well magnetic resonance angiography (MRA) predicts the severity of carotid stenosis in patients who have recently shown symptoms and have significant blockages (70% or worse). Researchers found that MRA often overestimated the severity of the stenosis, with misclassifications occurring in 7% of cases, especially in patients with more severe blockages. This is important because these errors could lead to incorrect treatment decisions and potential complications for patients. Who this helps: This information benefits doctors treating patients with carotid stenosis by highlighting potential inaccuracies in MRA.

Plain English
This study looked at a type of cancer called composite extrarenal rhabdoid tumors (CERTs) to see if they have the same genetic changes as related aggressive tumors. They found that 77% of atypical teratoid/rhabdoid tumors (AT/RTs) and 75% of malignant rhabdoid tumors (MRTs) had a specific genetic deletion on chromosome 22, while only 13% of CERTs showed this deletion. This matters because it suggests that CERTs do not develop from the same genetic changes as other rhabdoid tumors, indicating they might behave differently and require different treatment approaches. Who this helps: Patients with composite extrarenal rhabdoid tumors.